Treating Anal HSIL Cuts Anal Cancer Risk in Persons With HIV
The rate of progression to anal cancer was lower for patients receiving treatment for anal high-grade squamous intraepithelial lesions.
Gastrointestinal Cancer
Bariatric Surgery Cuts Obesity-Related Cancer Incidence
The cumulative incidence of obesity-related cancers at 10 years was 2.9% in the bariatric surgery group and 4.9% in the nonsurgical control group.
Sugar-Sweetened Drinks May Raise Risk for Liver Cancer
Replacing sugar-sweetened beverages with water and non-sugar-sweetened coffee or tea could significantly lower liver cancer risk, researchers said.
Additional Biopsies After CRC Biopsy Not Tied to Metachronous CRC
Biopsy of nontumor sites after initial colorectal cancer biopsy was not linked to a risk for metachronous cancer.
Decreases in Breast, Cervical Cancer Screening From 2018 to 2020
The prevalence of screening for colorectal cancer remained stable.
Radiation Segmentectomy Efficacious for Unresectable Liver Cancer
All patients had an initial objective response, 90% had a sustained complete response, and few patients had high-grade adverse events.
Eating Red Meat May Up Colorectal Cancer Risk in Black Women
Eating unprocessed red meat is associated with an increased risk of colorectal cancer in Black women.
Optimal Treatment Sequence for RAS/BRAF Wild-Type Metastatic Colorectal Cancer Still Unclear
There were no significant differences in most efficacy outcomes between 2 treatment sequences.
Intermittent FOLFIRI With Panitumumab Improves Outcomes in Metastatic Colorectal Cancer
A new study in untreated metastatic colorectal cancer met its progression-free survival endpoint for intermittent treatment with FOLFIRI and panitumumab.
Modified FOLFOX6 With Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer
Patients with RAS wild-type metastatic colorectal cancer had an improvement in overall survival when modified FOLFOX6 was combined with panitumumab vs bevacizumab.
- Loading...
Loading...
Loading... 
Loading...